Fanqiao Meng

Daping, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Organic cultivation on the Yungui plateau improves green tea flavor while reducing heavy metal accumulation.

Organic cultivation on the Yungui plateau improves green tea flavor while reducing heavy metal accumulation.

Journal: Food chemistry: X
Published: April 15, 2026

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients.

Journal: Frontiers in immunology
Published: October 10, 2025

Retrospective study on the clinical outcomes and characteristics of acute myeloid leukemia: different outcomes in the same risk group.

Retrospective study on the clinical outcomes and characteristics of acute myeloid leukemia: different outcomes in the same risk group.

Journal: PeerJ
Published: April 28, 2025

Case Report: Combined umbilical cord blood and peripheral blood stem cell transplantation with donor lymphocyte infusion for R/R AML post CAR-CLL1 failure.

Case Report: Combined umbilical cord blood and peripheral blood stem cell transplantation with donor lymphocyte infusion for R/R AML post CAR-CLL1 failure.

Journal: Frontiers in immunology
Published: March 23, 2025

Venetoclax Plus Daratumumab Bridging Allo-HSCT in Early T-Cell Precursor Acute Lymphoblastic Leukemia.

Venetoclax Plus Daratumumab Bridging Allo-HSCT in Early T-Cell Precursor Acute Lymphoblastic Leukemia.

Journal: Pediatric blood & cancer
Published: February 21, 2025

Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis.

Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis.

Journal: BMC cancer
Published: December 01, 2024

TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignancies.

TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignancies.

Journal: Annals of hematology
Published: June 26, 2024

Upregulation of S100A6 and its relation with CD34+ cells apoptosis in high-risk myelodysplastic syndromes patients.

Upregulation of S100A6 and its relation with CD34+ cells apoptosis in high-risk myelodysplastic syndromes patients.

Journal: Heliyon
Published: November 08, 2022

Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Hematologic Malignancy.

Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Hematologic Malignancy.

Journal: Transplantation and cellular therapy
Published: August 01, 2022

Donor-Derived CD7 CAR-T Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Acute T-Lymphocytic Leukemia Associated With Hepatitis B: A Case Report.

Donor-Derived CD7 CAR-T Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Acute T-Lymphocytic Leukemia Associated With Hepatitis B: A Case Report.

Journal: Frontiers in immunology
Published: April 29, 2022

TIM3/CEACAM1 pathway involves in myeloid-derived suppressor cells induced CD8+ T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome.

TIM3/CEACAM1 pathway involves in myeloid-derived suppressor cells induced CD8+ T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome.

Journal: Immunology
Published: December 05, 2021

The expression and clinical significance of CD59 and FLAER in Chinese adult AML patients.

The expression and clinical significance of CD59 and FLAER in Chinese adult AML patients.

Journal: Journal of clinical laboratory analysis
Published: September 16, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026